Loading…

CHD5 inhibits metastasis of neuroblastoma

CHD5 , a tumor suppressor at 1p36, is frequently lost or silenced in poor prognosis neuroblastoma (NB) and many adult cancers. The role of CHD5 in metastasis is unknown. We confirm that low expression of CHD5 is associated with stage 4 NB. Forced expression of CHD5 in NB cell lines with 1p loss inhi...

Full description

Saved in:
Bibliographic Details
Published in:Oncogene 2022-01, Vol.41 (5), p.622-633
Main Authors: Laut, Astrid K., Dorneburg, Carmen, Fürstberger, Axel, Barth, Thomas F. E., Kestler, Hans A., Debatin, Klaus-Michael, Beltinger, Christian
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c474t-2019d8393be7f3dfa1a75d25821ef2d3f2567c2757a55c205ab13a6d6984074c3
cites cdi_FETCH-LOGICAL-c474t-2019d8393be7f3dfa1a75d25821ef2d3f2567c2757a55c205ab13a6d6984074c3
container_end_page 633
container_issue 5
container_start_page 622
container_title Oncogene
container_volume 41
creator Laut, Astrid K.
Dorneburg, Carmen
Fürstberger, Axel
Barth, Thomas F. E.
Kestler, Hans A.
Debatin, Klaus-Michael
Beltinger, Christian
description CHD5 , a tumor suppressor at 1p36, is frequently lost or silenced in poor prognosis neuroblastoma (NB) and many adult cancers. The role of CHD5 in metastasis is unknown. We confirm that low expression of CHD5 is associated with stage 4 NB. Forced expression of CHD5 in NB cell lines with 1p loss inhibited key aspects of the metastatic cascade in vitro: anchorage-independent growth, migration, and invasion. In vivo, formation of bone marrow and liver metastases developing from intravenously injected NB cells was delayed and decreased by forced CHD5 expression. Genome-wide mRNA sequencing revealed reduction of genes and gene sets associated with metastasis when CHD5 was overexpressed. Known metastasis-suppressing genes preferentially upregulated in CHD5-overexpressing NB cells included PLCL1 . In patient NB, low expression of PLCL1was associated with metastatic disease and poor survival. Knockdown of PLCL1 and of p53 in IMR5 NB cells overexpressing CHD5 reversed CHD5-induced inhibition of invasion and migration in vitro. In summary, CHD5 is a metastasis suppressor in NB.
doi_str_mv 10.1038/s41388-021-02081-0
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8799470</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2623500556</sourcerecordid><originalsourceid>FETCH-LOGICAL-c474t-2019d8393be7f3dfa1a75d25821ef2d3f2567c2757a55c205ab13a6d6984074c3</originalsourceid><addsrcrecordid>eNp9kclOwzAQhi0EomV5AQ6oEhc4BMZbbF-QUFmKVIkLnC0ncdpUSVzsBIm3x6WlLAek8VjyfP494x-hEwyXGKi8CgxTKRMgOC6QMe-gIWYiTThXbBcNQXFIFKFkgA5CWACAUED20YAyIZWkaoguxpNbPqraeZVVXRg1tjMhRhVGrhy1tvcuq-OJa8wR2itNHezxZj9EL_d3z-NJMn16eBzfTJOcCdYlBLAqojTNrChpURpsBC8IlwTbkhS0JDwVORFcGM5zAtxkmJq0SJVkIFhOD9H1WnfZZ40tctt23tR66avG-HftTKV_V9pqrmfuTUuhFBMQBc43At699jZ0uqlCbuvatNb1QROuFAjOlIjo2R904XrfxvE0SQnlAJynkSJrKvcuBG_LbTMY9MoJvXZCRyf0pxN61cXpzzG2V76-PgJ0DYRYamfWf7_9j-wHxP2Sag</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2623500556</pqid></control><display><type>article</type><title>CHD5 inhibits metastasis of neuroblastoma</title><source>LexisNexis - News &amp; Business</source><source>Springer Link</source><creator>Laut, Astrid K. ; Dorneburg, Carmen ; Fürstberger, Axel ; Barth, Thomas F. E. ; Kestler, Hans A. ; Debatin, Klaus-Michael ; Beltinger, Christian</creator><creatorcontrib>Laut, Astrid K. ; Dorneburg, Carmen ; Fürstberger, Axel ; Barth, Thomas F. E. ; Kestler, Hans A. ; Debatin, Klaus-Michael ; Beltinger, Christian</creatorcontrib><description>CHD5 , a tumor suppressor at 1p36, is frequently lost or silenced in poor prognosis neuroblastoma (NB) and many adult cancers. The role of CHD5 in metastasis is unknown. We confirm that low expression of CHD5 is associated with stage 4 NB. Forced expression of CHD5 in NB cell lines with 1p loss inhibited key aspects of the metastatic cascade in vitro: anchorage-independent growth, migration, and invasion. In vivo, formation of bone marrow and liver metastases developing from intravenously injected NB cells was delayed and decreased by forced CHD5 expression. Genome-wide mRNA sequencing revealed reduction of genes and gene sets associated with metastasis when CHD5 was overexpressed. Known metastasis-suppressing genes preferentially upregulated in CHD5-overexpressing NB cells included PLCL1 . In patient NB, low expression of PLCL1was associated with metastatic disease and poor survival. Knockdown of PLCL1 and of p53 in IMR5 NB cells overexpressing CHD5 reversed CHD5-induced inhibition of invasion and migration in vitro. In summary, CHD5 is a metastasis suppressor in NB.</description><identifier>ISSN: 0950-9232</identifier><identifier>ISSN: 1476-5594</identifier><identifier>EISSN: 1476-5594</identifier><identifier>DOI: 10.1038/s41388-021-02081-0</identifier><identifier>PMID: 34789839</identifier><language>eng</language><publisher>London: Nature Publishing Group UK</publisher><subject>13 ; 13/51 ; 38/91 ; 42 ; 42/44 ; 59/5 ; 631/67/1678 ; 631/67/2332 ; 64/60 ; 82/80 ; Animals ; Apoptosis ; Bone growth ; Bone marrow ; Cell Biology ; Cell Line, Tumor ; Cell Movement - genetics ; DNA Helicases - genetics ; DNA Helicases - metabolism ; Gene expression ; Gene Expression Regulation, Neoplastic ; Genomes ; Human Genetics ; Humans ; Internal Medicine ; Medical prognosis ; Medicine ; Medicine &amp; Public Health ; Metastases ; Metastasis ; Mice ; mRNA ; Neoplasm Invasiveness - genetics ; Neoplasm Metastasis ; Nerve Tissue Proteins ; Neuroblastoma ; Neuroblastoma - genetics ; Neuroblastoma - metabolism ; Neuroblastoma - pathology ; Oncology ; p53 Protein ; Tumor suppressor genes ; Tumors</subject><ispartof>Oncogene, 2022-01, Vol.41 (5), p.622-633</ispartof><rights>The Author(s) 2021</rights><rights>2021. The Author(s).</rights><rights>The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c474t-2019d8393be7f3dfa1a75d25821ef2d3f2567c2757a55c205ab13a6d6984074c3</citedby><cites>FETCH-LOGICAL-c474t-2019d8393be7f3dfa1a75d25821ef2d3f2567c2757a55c205ab13a6d6984074c3</cites><orcidid>0000-0002-3527-9166 ; 0000-0002-4759-5254</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,776,780,881,27903,27904</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34789839$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Laut, Astrid K.</creatorcontrib><creatorcontrib>Dorneburg, Carmen</creatorcontrib><creatorcontrib>Fürstberger, Axel</creatorcontrib><creatorcontrib>Barth, Thomas F. E.</creatorcontrib><creatorcontrib>Kestler, Hans A.</creatorcontrib><creatorcontrib>Debatin, Klaus-Michael</creatorcontrib><creatorcontrib>Beltinger, Christian</creatorcontrib><title>CHD5 inhibits metastasis of neuroblastoma</title><title>Oncogene</title><addtitle>Oncogene</addtitle><addtitle>Oncogene</addtitle><description>CHD5 , a tumor suppressor at 1p36, is frequently lost or silenced in poor prognosis neuroblastoma (NB) and many adult cancers. The role of CHD5 in metastasis is unknown. We confirm that low expression of CHD5 is associated with stage 4 NB. Forced expression of CHD5 in NB cell lines with 1p loss inhibited key aspects of the metastatic cascade in vitro: anchorage-independent growth, migration, and invasion. In vivo, formation of bone marrow and liver metastases developing from intravenously injected NB cells was delayed and decreased by forced CHD5 expression. Genome-wide mRNA sequencing revealed reduction of genes and gene sets associated with metastasis when CHD5 was overexpressed. Known metastasis-suppressing genes preferentially upregulated in CHD5-overexpressing NB cells included PLCL1 . In patient NB, low expression of PLCL1was associated with metastatic disease and poor survival. Knockdown of PLCL1 and of p53 in IMR5 NB cells overexpressing CHD5 reversed CHD5-induced inhibition of invasion and migration in vitro. In summary, CHD5 is a metastasis suppressor in NB.</description><subject>13</subject><subject>13/51</subject><subject>38/91</subject><subject>42</subject><subject>42/44</subject><subject>59/5</subject><subject>631/67/1678</subject><subject>631/67/2332</subject><subject>64/60</subject><subject>82/80</subject><subject>Animals</subject><subject>Apoptosis</subject><subject>Bone growth</subject><subject>Bone marrow</subject><subject>Cell Biology</subject><subject>Cell Line, Tumor</subject><subject>Cell Movement - genetics</subject><subject>DNA Helicases - genetics</subject><subject>DNA Helicases - metabolism</subject><subject>Gene expression</subject><subject>Gene Expression Regulation, Neoplastic</subject><subject>Genomes</subject><subject>Human Genetics</subject><subject>Humans</subject><subject>Internal Medicine</subject><subject>Medical prognosis</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Metastases</subject><subject>Metastasis</subject><subject>Mice</subject><subject>mRNA</subject><subject>Neoplasm Invasiveness - genetics</subject><subject>Neoplasm Metastasis</subject><subject>Nerve Tissue Proteins</subject><subject>Neuroblastoma</subject><subject>Neuroblastoma - genetics</subject><subject>Neuroblastoma - metabolism</subject><subject>Neuroblastoma - pathology</subject><subject>Oncology</subject><subject>p53 Protein</subject><subject>Tumor suppressor genes</subject><subject>Tumors</subject><issn>0950-9232</issn><issn>1476-5594</issn><issn>1476-5594</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNp9kclOwzAQhi0EomV5AQ6oEhc4BMZbbF-QUFmKVIkLnC0ncdpUSVzsBIm3x6WlLAek8VjyfP494x-hEwyXGKi8CgxTKRMgOC6QMe-gIWYiTThXbBcNQXFIFKFkgA5CWACAUED20YAyIZWkaoguxpNbPqraeZVVXRg1tjMhRhVGrhy1tvcuq-OJa8wR2itNHezxZj9EL_d3z-NJMn16eBzfTJOcCdYlBLAqojTNrChpURpsBC8IlwTbkhS0JDwVORFcGM5zAtxkmJq0SJVkIFhOD9H1WnfZZ40tctt23tR66avG-HftTKV_V9pqrmfuTUuhFBMQBc43At699jZ0uqlCbuvatNb1QROuFAjOlIjo2R904XrfxvE0SQnlAJynkSJrKvcuBG_LbTMY9MoJvXZCRyf0pxN61cXpzzG2V76-PgJ0DYRYamfWf7_9j-wHxP2Sag</recordid><startdate>20220128</startdate><enddate>20220128</enddate><creator>Laut, Astrid K.</creator><creator>Dorneburg, Carmen</creator><creator>Fürstberger, Axel</creator><creator>Barth, Thomas F. E.</creator><creator>Kestler, Hans A.</creator><creator>Debatin, Klaus-Michael</creator><creator>Beltinger, Christian</creator><general>Nature Publishing Group UK</general><general>Nature Publishing Group</general><scope>C6C</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7TM</scope><scope>7TO</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>M7P</scope><scope>MBDVC</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>RC3</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-3527-9166</orcidid><orcidid>https://orcid.org/0000-0002-4759-5254</orcidid></search><sort><creationdate>20220128</creationdate><title>CHD5 inhibits metastasis of neuroblastoma</title><author>Laut, Astrid K. ; Dorneburg, Carmen ; Fürstberger, Axel ; Barth, Thomas F. E. ; Kestler, Hans A. ; Debatin, Klaus-Michael ; Beltinger, Christian</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c474t-2019d8393be7f3dfa1a75d25821ef2d3f2567c2757a55c205ab13a6d6984074c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>13</topic><topic>13/51</topic><topic>38/91</topic><topic>42</topic><topic>42/44</topic><topic>59/5</topic><topic>631/67/1678</topic><topic>631/67/2332</topic><topic>64/60</topic><topic>82/80</topic><topic>Animals</topic><topic>Apoptosis</topic><topic>Bone growth</topic><topic>Bone marrow</topic><topic>Cell Biology</topic><topic>Cell Line, Tumor</topic><topic>Cell Movement - genetics</topic><topic>DNA Helicases - genetics</topic><topic>DNA Helicases - metabolism</topic><topic>Gene expression</topic><topic>Gene Expression Regulation, Neoplastic</topic><topic>Genomes</topic><topic>Human Genetics</topic><topic>Humans</topic><topic>Internal Medicine</topic><topic>Medical prognosis</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Metastases</topic><topic>Metastasis</topic><topic>Mice</topic><topic>mRNA</topic><topic>Neoplasm Invasiveness - genetics</topic><topic>Neoplasm Metastasis</topic><topic>Nerve Tissue Proteins</topic><topic>Neuroblastoma</topic><topic>Neuroblastoma - genetics</topic><topic>Neuroblastoma - metabolism</topic><topic>Neuroblastoma - pathology</topic><topic>Oncology</topic><topic>p53 Protein</topic><topic>Tumor suppressor genes</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Laut, Astrid K.</creatorcontrib><creatorcontrib>Dorneburg, Carmen</creatorcontrib><creatorcontrib>Fürstberger, Axel</creatorcontrib><creatorcontrib>Barth, Thomas F. E.</creatorcontrib><creatorcontrib>Kestler, Hans A.</creatorcontrib><creatorcontrib>Debatin, Klaus-Michael</creatorcontrib><creatorcontrib>Beltinger, Christian</creatorcontrib><collection>SpringerOpen</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nucleic Acids Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Oncogene</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Laut, Astrid K.</au><au>Dorneburg, Carmen</au><au>Fürstberger, Axel</au><au>Barth, Thomas F. E.</au><au>Kestler, Hans A.</au><au>Debatin, Klaus-Michael</au><au>Beltinger, Christian</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>CHD5 inhibits metastasis of neuroblastoma</atitle><jtitle>Oncogene</jtitle><stitle>Oncogene</stitle><addtitle>Oncogene</addtitle><date>2022-01-28</date><risdate>2022</risdate><volume>41</volume><issue>5</issue><spage>622</spage><epage>633</epage><pages>622-633</pages><issn>0950-9232</issn><issn>1476-5594</issn><eissn>1476-5594</eissn><abstract>CHD5 , a tumor suppressor at 1p36, is frequently lost or silenced in poor prognosis neuroblastoma (NB) and many adult cancers. The role of CHD5 in metastasis is unknown. We confirm that low expression of CHD5 is associated with stage 4 NB. Forced expression of CHD5 in NB cell lines with 1p loss inhibited key aspects of the metastatic cascade in vitro: anchorage-independent growth, migration, and invasion. In vivo, formation of bone marrow and liver metastases developing from intravenously injected NB cells was delayed and decreased by forced CHD5 expression. Genome-wide mRNA sequencing revealed reduction of genes and gene sets associated with metastasis when CHD5 was overexpressed. Known metastasis-suppressing genes preferentially upregulated in CHD5-overexpressing NB cells included PLCL1 . In patient NB, low expression of PLCL1was associated with metastatic disease and poor survival. Knockdown of PLCL1 and of p53 in IMR5 NB cells overexpressing CHD5 reversed CHD5-induced inhibition of invasion and migration in vitro. In summary, CHD5 is a metastasis suppressor in NB.</abstract><cop>London</cop><pub>Nature Publishing Group UK</pub><pmid>34789839</pmid><doi>10.1038/s41388-021-02081-0</doi><tpages>12</tpages><orcidid>https://orcid.org/0000-0002-3527-9166</orcidid><orcidid>https://orcid.org/0000-0002-4759-5254</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0950-9232
ispartof Oncogene, 2022-01, Vol.41 (5), p.622-633
issn 0950-9232
1476-5594
1476-5594
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8799470
source LexisNexis - News & Business; Springer Link
subjects 13
13/51
38/91
42
42/44
59/5
631/67/1678
631/67/2332
64/60
82/80
Animals
Apoptosis
Bone growth
Bone marrow
Cell Biology
Cell Line, Tumor
Cell Movement - genetics
DNA Helicases - genetics
DNA Helicases - metabolism
Gene expression
Gene Expression Regulation, Neoplastic
Genomes
Human Genetics
Humans
Internal Medicine
Medical prognosis
Medicine
Medicine & Public Health
Metastases
Metastasis
Mice
mRNA
Neoplasm Invasiveness - genetics
Neoplasm Metastasis
Nerve Tissue Proteins
Neuroblastoma
Neuroblastoma - genetics
Neuroblastoma - metabolism
Neuroblastoma - pathology
Oncology
p53 Protein
Tumor suppressor genes
Tumors
title CHD5 inhibits metastasis of neuroblastoma
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-26T18%3A16%3A34IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=CHD5%20inhibits%20metastasis%20of%20neuroblastoma&rft.jtitle=Oncogene&rft.au=Laut,%20Astrid%20K.&rft.date=2022-01-28&rft.volume=41&rft.issue=5&rft.spage=622&rft.epage=633&rft.pages=622-633&rft.issn=0950-9232&rft.eissn=1476-5594&rft_id=info:doi/10.1038/s41388-021-02081-0&rft_dat=%3Cproquest_pubme%3E2623500556%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c474t-2019d8393be7f3dfa1a75d25821ef2d3f2567c2757a55c205ab13a6d6984074c3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2623500556&rft_id=info:pmid/34789839&rfr_iscdi=true